Learn more

CELERA CORP

Overview
  • Total Patents
    266
  • GoodIP Patent Rank
    16,916
  • Filing trend
    ⇩ 26.0%
About

CELERA CORP has a total of 266 patent applications. It decreased the IP activity by 26.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and Japan. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are WAYNE JOHN CANCER INST, SHAUGHNESSY JR JOHN D and LEE NANCY M.

Patent filings in countries

World map showing CELERA CORPs patent filings in countries

Patent filings per year

Chart showing CELERA CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Devlin James J 91
#2 Cargill Michele 79
#3 Iakoubova Olga 62
#4 Ruben Steve 37
#5 Luke May 30
#6 Huang Hongjin 30
#7 He Tao 28
#8 Devlin James 26
#9 Shiffman Dov 25
#10 Li Yonghong 24

Latest patents

Publication Filing date Title
US2014315844A1 Multi-gene signatures for predicting response to chemotherapy or risk of metastasis for breast cancer
US2014178362A1 Methods and compositions for treating diseases targeting maba
EP2635709A2 Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
US2011269735A1 Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
WO2010006215A1 Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
WO2010002891A1 Genetic polymorphisms associated with autoinflammatory diseases, methods of detection and uses thereof
CA2717045A1 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
US2009221620A1 Gentic polymorphisms associated with stroke, methods of detection and uses thereof
US2009203015A1 Multiplex assays for hormonal and growth factor receptors, and uses thereof
US2009162348A1 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
EP2227556A2 Lung cancer markers and uses thereof
US2009130682A1 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
US2009162346A1 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
US7842467B1 Breast disease targets and uses thereof
BRPI0811309A2 polymorphism in the expected receptivity of the apo (a) gene to treatment with acetylsalicylic acid.
US2008241846A1 Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
US7960100B1 Colon cancer targets and uses thereof
US7842466B1 Colon disease targets and uses thereof
CA2674907A1 A molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof
US7807392B1 Lung disease targets and uses thereof